Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026)
Cooper Companies' (COO) quarterly Non-Current Deffered Revenue came in at $208.8 million in Q2 2026, up 6.31% year-on-year from $196.4 million in Q2 2025, and up 1.16% quarter-over-quarter from $206.4 million in Q1 2026.
Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
Cooper Companies' Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $208.8 million for Q2 2026.
- On a quarterly basis, Non-Current Deffered Revenue rose 6.31% year-over-year to $208.8 million in Q2 2026; TTM through Apr 2026 was $208.8 million, a 6.31% increase from a year earlier, with the FY2025 full-year figure at $201.8 million, up 4.4% from the prior year.
- Non-Current Deffered Revenue advanced to $208.8 million in Q2 2026 per COO's latest filing, from $206.4 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $208.8 million in Q2 2026 and bottomed at $182.6 million in Q2 2023.
- The 5-year median for Non-Current Deffered Revenue is $193.4 million (2025), against an average of $194.1 million.
- Across the five-year window, Non-Current Deffered Revenue surged 198200.0% in 2022 and declined 7.11% in 2023, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $198.3 million in 2022, then retreated by 7.11% to $184.2 million in 2023, then grew by 4.94% to $193.3 million in 2024, then advanced by 4.4% to $201.8 million in 2025, then climbed by 3.47% to $208.8 million in 2026.
- Per Business Quant, the three latest COO Non-Current Deffered Revenue figures stand at $208.8 million (Q2 2026), $206.4 million (Q1 2026), and $201.8 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 163.15 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 208.80 Mn |
| Jan 31, 2026 | 206.40 Mn |
| Oct 31, 2025 | 201.80 Mn |
| Jul 31, 2025 | 199.40 Mn |
| Apr 30, 2025 | 196.40 Mn |
| Jan 31, 2025 | 193.40 Mn |
| Oct 31, 2024 | 193.30 Mn |
| Jul 31, 2024 | 190.80 Mn |
| Apr 30, 2024 | 188.60 Mn |
| Jan 31, 2024 | 186.30 Mn |
| Oct 31, 2023 | 184.20 Mn |
| Jul 31, 2023 | 185.50 Mn |
| Apr 30, 2023 | 182.60 Mn |
| Jan 31, 2023 | 195.10 Mn |
| Oct 31, 2022 | 198.30 Mn |
| Oct 31, 2021 | 100,000.00 |